Tredje AP-fonden’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $101M | Buy |
841,448
+132,188
| +19% | +$15.3M | 0.55% | 29 |
|
|
2025
Q4 | $74.7M | Buy |
709,260
+78,195
| +12% | +$7.34M | 0.56% | 39 |
|
|
2025
Q3 | $53M | Buy |
631,065
+55,902
| +10% | +$4.6M | 0.43% | 53 |
|
|
2025
Q2 | $45.5M | Sell |
575,163
-347,631
| -38% | -$27.6M | 0.36% | 63 |
|
|
2025
Q1 | $82.8M | Buy |
922,794
+118,965
| +15% | +$11.1M | 0.77% | 34 |
|
|
2024
Q4 | $80M | Buy |
803,829
+77,537
| +11% | +$7.99M | 0.72% | 32 |
|
|
2024
Q3 | $82.5M | Sell |
726,292
-182,130
| -20% | -$21.6M | 0.75% | 32 |
|
|
2024
Q2 | $112M | Buy |
908,422
+49,400
| +6% | +$6.36M | 1.09% | 21 |
|
|
2024
Q1 | $113M | Buy |
859,022
+257,000
| +43% | +$31.7M | 1.18% | 15 |
|
|
2023
Q4 | $65.6M | Buy |
602,022
+67,130
| +13% | +$6.97M | 0.82% | 28 |
|
|
2023
Q3 | $55.1M | Buy |
534,892
+10,452
| +2% | +$1.13M | 0.81% | 28 |
|
|
2023
Q2 | $60.5M | Buy |
524,440
+25,153
| +5% | +$2.86M | 0.86% | 24 |
|
|
2023
Q1 | $53.1M | Sell |
499,287
-43,553
| -8% | -$4.7M | 0.83% | 25 |
|
|
2022
Q4 | $60.2M | Buy |
542,840
+96,824
| +22% | +$9.9M | 1.03% | 18 |
|
|
2022
Q3 | $38.4M | Buy |
446,016
+183,813
| +70% | +$16.4M | 0.8% | 24 |
|
|
2022
Q2 | $23.9M | Hold |
262,203
| – | – | 0.6% | 37 |
|
|
2022
Q1 | $21.5M | Hold |
262,203
| – | – | 0.44% | 50 |
|
|
2021
Q4 | $20.1M | Hold |
262,203
| – | – | 0.39% | 55 |
|
|
2021
Q3 | $19.7M | Hold |
262,203
| – | – | 0.41% | 55 |
|
|
2021
Q2 | $20.4M | Sell |
262,203
-12,586
| -5% | -$936K | 0.42% | 52 |
|
|
2021
Q1 | $20.2M | Hold |
274,789
| – | – | 0.48% | 57 |
|
|
2020
Q4 | $21.4M | Hold |
274,789
| – | – | 0.55% | 51 |
|
|
2020
Q3 | $21.8M | Hold |
274,789
| – | – | 0.71% | 37 |
|
|
2020
Q2 | $20.3M | Sell |
274,789
-26,307
| -9% | -$1.98M | 0.84% | 24 |
|
|
2020
Q1 | $22.1M | Sell |
301,096
-11,907
| -4% | -$936K | 1.15% | 19 |
|
|
2019
Q4 | $27.3M | Sell |
313,003
-24,756
| -7% | -$2.03M | 1.38% | 8 |
|
|
2019
Q3 | $27.3M | Buy |
337,759
+2,842
| +0.8% | +$228K | 1.31% | 12 |
|
|
2019
Q2 | $27M | Sell |
334,917
-6,294
| -2% | -$482K | 1.29% | 13 |
|
|
2019
Q1 | $27.3M | Buy |
341,211
+19,549
| +6% | +$1.46M | 1.41% | 10 |
|
|
2018
Q4 | $23.6M | Sell |
321,662
-75,396
| -19% | -$5.32M | 1.44% | 9 |
|
|
2018
Q3 | $27.1M | Sell |
397,058
-108,812
| -22% | -$6.93M | 1.3% | 9 |
|
|
2018
Q2 | $29.5M | Buy |
505,870
+7,668
| +2% | +$433K | 1.02% | 13 |
|
|
2018
Q1 | $26.1M | Buy |
498,202
+19,081
| +4% | +$1.03M | 0.93% | 15 |
|
|
2017
Q4 | $25.9M | Buy |
479,121
+64,158
| +15% | +$3.56M | 0.88% | 18 |
|
|
2017
Q3 | $25.5M | Sell |
414,963
-954
| -0.2% | -$57.8K | 0.9% | 10 |
|
|
2017
Q2 | $25.6M | Sell |
415,917
-60,081
| -13% | -$3.66M | 0.95% | 11 |
|
|
2017
Q1 | $29.1M | Buy |
475,998
+13,766
| +3% | +$835K | 1.15% | 7 |
|
|
2016
Q4 | $26.2M | Buy |
462,232
+24,471
| +6% | +$1.43M | 1.11% | 7 |
|
|
2016
Q3 | $26.3M | Sell |
437,761
-5,802
| -1% | -$339K | 1.19% | 8 |
|
|
2016
Q2 | $24.6M | Sell |
443,563
-30,772
| -6% | -$1.64M | 1.1% | 12 |
|
|
2016
Q1 | $24.6M | Buy |
474,335
+92,795
| +24% | +$4.54M | 1.12% | 12 |
|
|
2015
Q4 | $19.4M | Buy |
381,540
+188,139
| +97% | +$9.49M | 1.24% | 12 |
|
|
2015
Q3 | $9.21M | Sell |
193,401
-209,783
| -52% | -$11.1M | 0.9% | 26 |
|
|
2015
Q2 | $22M | Buy |
+403,184
| New | +$22.6M | 1.76% | 10 |
|
Other funds holding MRK
VCM
VPM
Tredje AP-fonden's MRK Position: Q1 2026 in Review
Tredje AP-fonden increased its Merck (MRK) stake by 19% in Q1 2026, buying an estimated $15.3M and bringing the position to 841,448 shares worth $101M. The position accounts for 0.55% of the portfolio, ranked #29.
Tredje AP-fonden first reported a position in MRK in Q2 2015 and has held it in 44 quarters since. The position peaked at $113M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Tredje AP-fonden held 841,448 shares of Merck worth $101M as of Q1 2026.
- Tredje AP-fonden bought 132,188 Merck shares in Q1 2026, an estimated $15.3M.
- Merck made up 0.55% of Tredje AP-fonden's portfolio in Q1 2026, its #29 holding.
- Tredje AP-fonden first reported a position in Merck in Q2 2015 and has held it in 44 quarters since.
- Tredje AP-fonden's Merck position peaked at $113M in Q1 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Tredje AP-fonden's 13F filing for Q1 2026, filed 12 May 2026.